Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 56,972 | 44,910 | 42,032 | 46,466 | 56,615 |
| Operating Income | -56,972 | -44,910 | -42,032 | -46,466 | -56,615 |
| Interest Expense | 2,425 | 2,417 | 2,408 | 2,400 | 2,392 |
| Other Income | 571 | 3,642 | 138 | -203 | 14 |
| Pre-tax Income | -58,826 | -43,685 | -44,302 | -49,069 | -58,993 |
| Net Income Continuous | -58,826 | -43,685 | -44,302 | -49,069 | -58,993 |
| Minority Interests | -18 | -47 | -5 | -2 | -4 |
| Net Income | $-58,808 | $-43,638 | $-44,297 | $-49,067 | $-58,989 |
| EPS Basic Total Ops | -0.87 | -0.68 | -0.74 | -0.77 | -1.09 |
| EPS Basic Continuous Ops | -0.87 | -0.68 | -0.74 | -0.78 | -1.09 |
| EPS Diluted Total Ops | -0.87 | -0.68 | -0.74 | -0.77 | -1.09 |
| EPS Diluted Continuous Ops | -0.87 | -0.68 | -0.74 | -0.78 | -1.09 |
| EBITDA(a) | $-56,060 | $-44,122 | $-41,110 | $-45,540 | $-55,845 |